Table 2.
Liver hormone
|
Target organ
|
Action on target organ
|
Alteration in liver diseases
|
Amino acids | Pancreatic α cells | Stimulate cell proliferation and glucagon secretion | Not studied yet |
Betatrophin | Pancreatic β cells (?) | Stimulate cell proliferation (?) | Increased in cirrhosis |
Fetuin | Skeletal muscle; Adipose tissue | Decrease insulin sensitivity; Reduce adiponectin expression | Elevated in nonalcoholic fatty liver disease |
FGF21 | Adipose tissue; Brain | Increase insulin sensitivity; Reduce food intake | Elevated in nonalcoholic fatty liver disease |
Activin E | Adipose tissue | Increase fat oxidation | Increased in nonalcoholic fatty liver disease |
Tsukushi | Adipose tissue | Increase thermogenesis | Increased in nonalcoholic fatty liver disease |
GPNMB | Adipose tissue | Increase lipogenesis | Increased in nonalcoholic fatty liver disease |
FGF21: Fibroblast growth factor 21; GPNMB: Glycoprotein nonmetastatic melanoma protein B.